The South China Morning Post has published an analysis arguing that "reverse tech transfer" from China will not take hold in the US auto industry — a claim with direct implications for how American R&D managers benchmark Chinese automotive technology and structure supplier and licensing relationships.

The piece's central proposition runs against a decade of commentary suggesting the direction of technology flow between the two auto sectors was fixed: Western and Japanese automakers would transfer platforms, powertrain know-how and manufacturing methods into Chinese joint ventures, and the intellectual property would largely stay put. That assumption no longer holds unconditionally. Chinese battery-electric vehicle engineering, particularly in battery packs, range-extended powertrains and cost-engineered platforms, has advanced to the point where Western incumbents now look to Chinese designs as reference points.

Yet the SCMP analysis concludes that a genuine reversal — Chinese firms licensing or transferring core technology into US production on the scale that once flowed the other way — will not happen. For R&D and portfolio managers at US automakers and tier-one suppliers, the argument matters because it frames a concrete question: if Chinese EV technology cannot enter the US market through formal transfer, which alternative channels — local engineering, offshore joint ventures, or component sourcing — will carry the cost and performance lessons instead?

The barriers the analysis points to are structural rather than technical. US tariff policy and inbound-investment restrictions on Chinese automotive and battery supply chains are the most visible. They make direct technology licensing into US plants commercially unattractive and politically exposed. Any R&D director evaluating a Chinese platform license or battery partnership must now price in regulatory risk across the full product cycle, not just at contract signing.

The second barrier is institutional. When technology flowed into China, the receiving side had scale, state coordination and a policy mandate to absorb it. The US auto industry presents no equivalent absorbing mechanism. Its OEMs compete with each other, guard proprietary architectures closely, and answer to shareholders who reward margin protection over aggressive technology acquisition from a geopolitical rival. No US automaker has the incentive structure that Chinese joint-venture partners had in the 1990s and 2000s.

Third, the analysis implies an asymmetry in what each side actually needs. Chinese automakers built their position by learning manufacturing discipline and platform engineering from foreign partners, then competing on cost. US automakers facing Chinese EV competition need cost reduction and electrification speed — capabilities that are embedded in supply chains and production systems as much as in patentable designs. That kind of knowledge does not transfer cleanly through licensing agreements. It transfers through joint manufacturing, supplier integration and shared development programs, exactly the structures that current US policy discourages.

The practical consequence for US R&D managers is a workflow question. Benchmarking Chinese vehicles through teardown analysis, hiring engineers with relevant experience, and sourcing components through third markets remain available. Formal reverse transfer — licensed platforms, joint plants on US soil, co-development contracts — does not, at least under the policy environment the analysis describes.

The claim deserves the same scrutiny any vendor or institute assertion would get. The piece is an analytical argument, not a measured result, and its author's framing reflects SCMP's vantage point on US-China industrial policy. Competing analyses have argued that some technology flow persists through less visible channels — battery materials agreements, engineering-services contracts and licensing into non-US markets — and that the blockage is specific to the American market rather than global. Portfolio planners should treat the conclusion as a scenario to model, not a settled fact.

What the analysis does establish is that the direction-of-flow question has become a live planning variable. For the next product cycle, US auto R&D leadership will need to decide whether Chinese EV technology is a threat to defend against through tariffs, a benchmark to match through internal development, or a partner to work around through offshore structures. The SCMP argument suggests the first and second paths will dominate, and that formal reverse transfer — whatever its technical logic — will stay off the table in the US market for the foreseeable future.